Archive for November, 2010
The fight against cancer in poor countries need not be expensive
Many cancers that pose the greatest burden on low-income nations could be treated generically manufactured drugs at affordable prices. The growing impact of cancer in developing countries could be reduced without drugs and expensive equipment, scientists said on Monday, but requires a similar global effort to combat HIV.
In a study in Lancet, scientists from the United States, who have formed a Global Task Force on Greater Access to Cancer Treatment in Developing Countries (GTF.CCC by its acronym in English), noted that cancer is currently killer in poor nations. Read the rest of this entry »
Understanding Breast Cancer Risk
When estimating the baseline risk of a healthy woman developing breast cancer, the statistic often quoted is 1 out of 8. This often leads to much anxiety, since a 12.5% risk of developing cancer is frighteningly high. However, this is a cumulative risk over one’s lifetime, and half of this risk actually occurs after a woman reaches the age of 65 years.
The following represents a broad overview of factors associated with breast cancer risk, methods to measure breast cancer risk, and options available to women at high risk of developing the disease. Many of these topics are discussed in greater detail in other feature articles in the November Focus and will be discussed throughout the month during Healthology Live audio broadcasts. We encourage you to read on and tune in. Read the rest of this entry »
Cancer research: Green tea prevents cancer of the blood
Green tea may reduce the risk of developing certain types of blood cancer, but this one should drink at least five cups a day. Scientists from the Medical School at Tohoku University (Japan) have been known that green tea reduces the risk of premature death and of heart disease. The latest research has revealed yet another beneficial effect of this drink.
Specialists have gathered information about the nutritional 19,749 men and 22,012 women aged 40 to 79 years, then nine years were subjects for observation. At the beginning of the study cancer of the blood or lymphatic system was not diagnosed with any one respondent. Read the rest of this entry »
The success of the treatment of colon cancer
The success of the treatment of colon cancer greatly depends on what stage of development failed to detect disease. In the diagnosis of bowel cancer guideline still holds koloskopii method. However, this procedure is fairly costly and uncomfortable for the patient. That’s why researchers are already developing, aimed at establishing reliable methods for determination of bowel cancer by analyzing blood samples. New protein is called “specific antigen colon – 2» (colon-canser-specific-antigen-2, CCSA-2) Scientists believe that the new test can help diagnose cancer of the colon and rectum at the earliest stages of its development.
The purpose of the test is to identify a specific blood protein that in patients with colorectal cancer occurs more frequently and in greater concentrations than in healthy people. Doctors claim that the simultaneous determination in blood and still others, already known to date, tumor markers increase the accuracy of diagnosis. Read the rest of this entry »